Antitrust & Trade Reg.
Apr. 28, 2017
Final approval of prescription drug settlement nets $399 million for class members
A San Diego County judge has approved a $225 million class action settlement between consumers and the final defendant pharmaceutical company in an antitrust lawsuit that nets nearly $400 million for class members.
Daily Journal Staff Writer
Calling the matter "extraordinary," a San Diego County judge has approved a $225 million class action settlement between consumers and a remaining pharmaceutical company defendant, bringing to an end a long-running antitrust lawsuit that has now netted nearly $400 million for class members.
The case, over 17 years in the making, lost at the trial and appellate level be...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In